NEW YORK, March 28 – Genometrix of The Woodlands, Texas, said Wednesday it had reached an agreement to provide SNP-discovery services for Agouron Pharmaceuticals, a subsidiary of Pfizer.

Genometrix did not disclose the terms of the deal, which resulted following a SNP-discovery pilot project.

Spokespeople for Genometrix and Agouron were not immediately available for comment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.